NCT05013944 AnovaOS Network Powered Patient Registry
| NCT ID | NCT05013944 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Anova Enterprises, Inc |
| Condition | Infectious Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 100,000 participants |
| Start Date | 2021-09-01 |
| Primary Completion | 2025-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100,000 participants in total. It began in 2021-09-01 with a primary completion date of 2025-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.
Eligibility Criteria
Inclusion Criteria: * 18 years old or older; * Confirmed positive diagnosis of disease, condition or disorder. This will be self-reported or reported by the patient's provider, advocacy group or other patient representative; * Laboratory or other independent means of confirmation is not required but may be confirmed in clinical trials; * Able to understand and willing to sign the informed consent document; or whose legal representative has given consent to participate in the research per state and Federal requirements; * Willing and able to complete the registry questions or have the instrument(s) completed by an informed proxy; * Anticipated additional follow up with the registry once per year. Exclusion Criteria: * Subjects who do not meet the inclusion criteria for the study; * Subjects who are unable to understand the protocol or unable to provide legally effective informed consent
Contact & Investigator
Martin Walsh
STUDY DIRECTOR
Anova Enterprises, Inc
Frequently Asked Questions
Who can join the NCT05013944 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Infectious Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05013944 currently recruiting?
Yes, NCT05013944 is actively recruiting participants. Contact the research team at chris@anovaevidence.com for enrollment information.
Where is the NCT05013944 trial being conducted?
This trial is being conducted at Arlington Heights, United States.
Who is sponsoring the NCT05013944 clinical trial?
NCT05013944 is sponsored by Anova Enterprises, Inc. The principal investigator is Martin Walsh at Anova Enterprises, Inc. The trial plans to enroll 100,000 participants.